Considering the significance of HER2 status diagnosis and the limitations of current computational methods, we propose the neural network model HAHNet to aid pathologists in better assessing HER2 status and to help more breast cancer patients receive improved treatment plans. The gene discussed is ERBB2; the disease is breast carcinoma.